We are live on ! Find out more
IRMD icon

iRadimed
IRMD

51 hedge funds and large institutions have $44M invested in iRadimed in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

750% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 2

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

66% more capital inflows, than outflows

Capital inflows: $10.2M | Capital outflows: $6.18M

42% more funds holding

Funds holding: 36 → 51 (+15)

1.91% more ownership

Funds ownership: 18% → 19.91% (+1.9%)

Holders
51
Holders Change
+15
Holders Change %
+41.67%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
11
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.29M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.13M
3
Ranger Investment Management
Ranger Investment Management
Texas
+$758K
4
Timpani Capital Management
Timpani Capital Management
Wisconsin
+$628K
5
State Street
State Street
Massachusetts
+$577K

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$3.21M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$805K
3
Eversept Partners
Eversept Partners
New York
-$591K
4
Mondrian Investment Partners
Mondrian Investment Partners
United Kingdom
-$528K
5
Unison Advisors
Unison Advisors
District of Columbia
-$413K

IRMD Hedge Fund Activity: Q2 2018 in Review

51 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2018, worth a combined $44M — up 59% from $27.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IRMD positions and 2 closed out — a net gain of 15 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $3.29M. The largest seller was Ameriprise, cutting an estimated $3.21M.

  • 51 institutional investors held iRadimed (IRMD) as of Q2 2018, up from 36 in Q1 2018.
  • Funds reported $44M of iRadimed stock for Q2 2018, up 59% quarter-over-quarter.
  • 17 funds opened new iRadimed positions in Q2 2018 and 2 closed out, a net change of +15 holders.
  • The largest iRadimed buyer in Q2 2018 was BlackRock, an estimated $3.29M added.
  • The largest iRadimed seller in Q2 2018 was Ameriprise, an estimated $3.21M sold.

Based on aggregated 13F filings for Q2 2018.